International variations and trends in testicular cancer incidence and mortality

Ariana Znaor, Joannie Lortet-Tieulent, Ahmedin Jemal, Freddie Ian Bray

Research output: Contribution to journalReview article

106 Citations (Scopus)

Abstract

Context Testicular cancer (TC) is the most common cancer in men aged 15-44 yr in many countries that score high or very high on the Human Development Index (HDI). Despite the very good prognosis for TC, wide variations in mortality rates have been reported internationally. Objective To describe and contrast global variations and recent trends in TC incidence and mortality rates. Evidence acquisition To compare TC incidence and mortality rates, we used GLOBOCAN 2008 estimates. We used the Cancer Incidence in Five Continents series to analyse recent trends in TC incidence in 41 countries by way of joinpoint analysis. To examine recent trends in mortality, we used the World Health Organisation mortality database. Evidence synthesis Northern Europe remains the highest TC incidence area, with the highest rates observed in Norway and Denmark. Incidence rates continue to increase in most countries worldwide, more markedly in Southern Europe and Latin America, while attenuating in Northern Europe, the United States, and Australia. Mortality from TC shows a different pattern, with higher rates in some countries of medium to high HDI. The highest mortality rates were seen in Chile and Latvia, as well as in selected Central European and Eastern European countries. In high-income countries, TC mortality rates are declining or stable at very low levels of magnitude, while no significant decreases were observed in middle-income regions in Latin America and Asia. Conclusions The rises in TC incidence appear to be recently attenuating in countries with the highest HDIs, with corresponding mortality rates either continuing to decline or stabilising at very low levels. In a number of countries transiting towards higher levels of development, the TC incidence is increasing while mortality rates are stable or increasing. Patient summary In this study we looked at international testicular cancer trends. We found that testicular cancer is becoming more common in low- and middle-income countries, where the optimal treatment might not yet be available.

Original languageEnglish (US)
Pages (from-to)1095-1106
Number of pages12
JournalEuropean Urology
Volume65
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Testicular Neoplasms
Mortality
Incidence
Latin America
Human Development
Latvia
Chile
Denmark
Norway
Neoplasms
Databases

Keywords

  • Cancer trends
  • International variation
  • Testicular cancer

ASJC Scopus subject areas

  • Urology

Cite this

International variations and trends in testicular cancer incidence and mortality. / Znaor, Ariana; Lortet-Tieulent, Joannie; Jemal, Ahmedin; Bray, Freddie Ian.

In: European Urology, Vol. 65, No. 6, 01.01.2014, p. 1095-1106.

Research output: Contribution to journalReview article

Znaor, Ariana ; Lortet-Tieulent, Joannie ; Jemal, Ahmedin ; Bray, Freddie Ian. / International variations and trends in testicular cancer incidence and mortality. In: European Urology. 2014 ; Vol. 65, No. 6. pp. 1095-1106.
@article{bff5045bd89244d8aaa81d84cb5086dc,
title = "International variations and trends in testicular cancer incidence and mortality",
abstract = "Context Testicular cancer (TC) is the most common cancer in men aged 15-44 yr in many countries that score high or very high on the Human Development Index (HDI). Despite the very good prognosis for TC, wide variations in mortality rates have been reported internationally. Objective To describe and contrast global variations and recent trends in TC incidence and mortality rates. Evidence acquisition To compare TC incidence and mortality rates, we used GLOBOCAN 2008 estimates. We used the Cancer Incidence in Five Continents series to analyse recent trends in TC incidence in 41 countries by way of joinpoint analysis. To examine recent trends in mortality, we used the World Health Organisation mortality database. Evidence synthesis Northern Europe remains the highest TC incidence area, with the highest rates observed in Norway and Denmark. Incidence rates continue to increase in most countries worldwide, more markedly in Southern Europe and Latin America, while attenuating in Northern Europe, the United States, and Australia. Mortality from TC shows a different pattern, with higher rates in some countries of medium to high HDI. The highest mortality rates were seen in Chile and Latvia, as well as in selected Central European and Eastern European countries. In high-income countries, TC mortality rates are declining or stable at very low levels of magnitude, while no significant decreases were observed in middle-income regions in Latin America and Asia. Conclusions The rises in TC incidence appear to be recently attenuating in countries with the highest HDIs, with corresponding mortality rates either continuing to decline or stabilising at very low levels. In a number of countries transiting towards higher levels of development, the TC incidence is increasing while mortality rates are stable or increasing. Patient summary In this study we looked at international testicular cancer trends. We found that testicular cancer is becoming more common in low- and middle-income countries, where the optimal treatment might not yet be available.",
keywords = "Cancer trends, International variation, Testicular cancer",
author = "Ariana Znaor and Joannie Lortet-Tieulent and Ahmedin Jemal and Bray, {Freddie Ian}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.eururo.2013.11.004",
language = "English (US)",
volume = "65",
pages = "1095--1106",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "6",

}

TY - JOUR

T1 - International variations and trends in testicular cancer incidence and mortality

AU - Znaor, Ariana

AU - Lortet-Tieulent, Joannie

AU - Jemal, Ahmedin

AU - Bray, Freddie Ian

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Context Testicular cancer (TC) is the most common cancer in men aged 15-44 yr in many countries that score high or very high on the Human Development Index (HDI). Despite the very good prognosis for TC, wide variations in mortality rates have been reported internationally. Objective To describe and contrast global variations and recent trends in TC incidence and mortality rates. Evidence acquisition To compare TC incidence and mortality rates, we used GLOBOCAN 2008 estimates. We used the Cancer Incidence in Five Continents series to analyse recent trends in TC incidence in 41 countries by way of joinpoint analysis. To examine recent trends in mortality, we used the World Health Organisation mortality database. Evidence synthesis Northern Europe remains the highest TC incidence area, with the highest rates observed in Norway and Denmark. Incidence rates continue to increase in most countries worldwide, more markedly in Southern Europe and Latin America, while attenuating in Northern Europe, the United States, and Australia. Mortality from TC shows a different pattern, with higher rates in some countries of medium to high HDI. The highest mortality rates were seen in Chile and Latvia, as well as in selected Central European and Eastern European countries. In high-income countries, TC mortality rates are declining or stable at very low levels of magnitude, while no significant decreases were observed in middle-income regions in Latin America and Asia. Conclusions The rises in TC incidence appear to be recently attenuating in countries with the highest HDIs, with corresponding mortality rates either continuing to decline or stabilising at very low levels. In a number of countries transiting towards higher levels of development, the TC incidence is increasing while mortality rates are stable or increasing. Patient summary In this study we looked at international testicular cancer trends. We found that testicular cancer is becoming more common in low- and middle-income countries, where the optimal treatment might not yet be available.

AB - Context Testicular cancer (TC) is the most common cancer in men aged 15-44 yr in many countries that score high or very high on the Human Development Index (HDI). Despite the very good prognosis for TC, wide variations in mortality rates have been reported internationally. Objective To describe and contrast global variations and recent trends in TC incidence and mortality rates. Evidence acquisition To compare TC incidence and mortality rates, we used GLOBOCAN 2008 estimates. We used the Cancer Incidence in Five Continents series to analyse recent trends in TC incidence in 41 countries by way of joinpoint analysis. To examine recent trends in mortality, we used the World Health Organisation mortality database. Evidence synthesis Northern Europe remains the highest TC incidence area, with the highest rates observed in Norway and Denmark. Incidence rates continue to increase in most countries worldwide, more markedly in Southern Europe and Latin America, while attenuating in Northern Europe, the United States, and Australia. Mortality from TC shows a different pattern, with higher rates in some countries of medium to high HDI. The highest mortality rates were seen in Chile and Latvia, as well as in selected Central European and Eastern European countries. In high-income countries, TC mortality rates are declining or stable at very low levels of magnitude, while no significant decreases were observed in middle-income regions in Latin America and Asia. Conclusions The rises in TC incidence appear to be recently attenuating in countries with the highest HDIs, with corresponding mortality rates either continuing to decline or stabilising at very low levels. In a number of countries transiting towards higher levels of development, the TC incidence is increasing while mortality rates are stable or increasing. Patient summary In this study we looked at international testicular cancer trends. We found that testicular cancer is becoming more common in low- and middle-income countries, where the optimal treatment might not yet be available.

KW - Cancer trends

KW - International variation

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=84899495027&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899495027&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2013.11.004

DO - 10.1016/j.eururo.2013.11.004

M3 - Review article

C2 - 24268506

AN - SCOPUS:84899495027

VL - 65

SP - 1095

EP - 1106

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 6

ER -